Targeted mutation detection in breast cancer using MammaSeq™

Targeted mutation detection in breast cancer using MammaSeq™

Abstract Background Breast cancer is the most common invasive cancer among women worldwide. Next-generation sequencing (NGS) has revolutionized the study of cancer across research labs around the globe; however, genomic testing in clinical settings remains limited. Advances in sequencing reliability...

Full description

Bibliographic Details
Main Authors: Nicholas G. Smith, Rekha Gyanchandani, Osama S. Shah, Grzegorz T. Gurda, Peter C. Lucas, Ryan J. Hartmaier, Adam M. Brufsky, Shannon Puhalla, Amir Bahreini, Karthik Kota, Abigail I. Wald, Yuri E. Nikiforov, Marina N. Nikiforova, Steffi Oesterreich, Adrian V. Lee
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Breast Cancer Research
Subjects:
Breast cancer
Targeted sequencing
ctDNA
Clinical utility
Tumor burden
Online Access:http://link.springer.com/article/10.1186/s13058-019-1102-7

Internet

http://link.springer.com/article/10.1186/s13058-019-1102-7

Similar Items